FDA accepts GSK's filing to extend Arexvy's RSV vaccine use to high-risk adults under 50, with a decision due in 2026.

GSK has applied to the US Food and Drug Administration (FDA) to extend use of its respiratory syncytial virus (RSV) vaccine Arexvy to adults under the age of 50 who are at increased risk of the ...

The update covers the safety and appropriate timing of vaccinations, screening for osteoporosis, cervical cancer, skin cancer ...

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

While your baby may not have made his big entrance yet, it's important to understand the recommended vaccines and schedule now. That's because your child’s immunizations will play a major role during ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

Cases of COVID-19 are on the rise or likely rising across half of the U.S. including much of the south as well as the West Coast, according to a weekly update from the Centers for Disease Control and ...

The diagnosis was confirmed through rapid testing after the Coconino County resident was admitted to Flagstaff Medical Center. Pneumonic plague is the only form of the plague that can be transmitted ...

European trade ministers were hopeful for a negotiated trade deal after Trump announced 30% tariffs on the European Union.